{'Year': '2014', 'Month': 'Aug'}
Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.
The genetic background of antidepressant response represents a unique opportunity to identify biological markers of treatment outcome. Encouraging results alternating with inconsistent findings made antidepressant pharmacogenetics a stimulating but often discouraging field that requires careful discussion about cumulative evidence and methodological issues.